Amol D. Dhamane

1.1k total citations
51 papers, 778 citations indexed

About

Amol D. Dhamane is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Economics and Econometrics. According to data from OpenAlex, Amol D. Dhamane has authored 51 papers receiving a total of 778 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Cardiology and Cardiovascular Medicine, 21 papers in Internal Medicine and 10 papers in Economics and Econometrics. Recurrent topics in Amol D. Dhamane's work include Atrial Fibrillation Management and Outcomes (36 papers), Venous Thromboembolism Diagnosis and Management (21 papers) and Cardiac Arrhythmias and Treatments (16 papers). Amol D. Dhamane is often cited by papers focused on Atrial Fibrillation Management and Outcomes (36 papers), Venous Thromboembolism Diagnosis and Management (21 papers) and Cardiac Arrhythmias and Treatments (16 papers). Amol D. Dhamane collaborates with scholars based in United States, United Kingdom and Denmark. Amol D. Dhamane's co-authors include Anna O. D’Souza, Manan Shah, Hüseyin Yüce, Richard H. Stanford, Michael Schätz, Xuemei Luo, Allison Keshishian, Lisa Rosenblatt, Shuchita Kaila and Jack Mardekian and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Journal of the American College of Cardiology.

In The Last Decade

Amol D. Dhamane

49 papers receiving 764 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Amol D. Dhamane United States	17	378	300	199	192	130	51	778
Judith S. Hurley United States	14	218 0.6×	198 0.7×	178 0.9×	86 0.4×	116 0.9×	18	655
Carole Bradley-Kennedy Canada	6	223 0.6×	251 0.8×	58 0.3×	100 0.5×	90 0.7×	8	500
Gualberto Gussoni Italy	14	174 0.5×	54 0.2×	55 0.3×	60 0.3×	91 0.7×	42	530
Thomas M. Jaeger United States	12	251 0.7×	45 0.1×	156 0.8×	49 0.3×	74 0.6×	18	757
Joanne Cuny United States	12	207 0.5×	72 0.2×	205 1.0×	43 0.2×	91 0.7×	20	739
Paula Dias Portugal	14	467 1.2×	190 0.6×	25 0.1×	35 0.2×	169 1.3×	46	746
Manuel Montero-Pérez-Barquero Spain	18	624 1.7×	109 0.4×	22 0.1×	35 0.2×	104 0.8×	69	783
Michael W. Cullen United States	16	390 1.0×	87 0.3×	31 0.2×	20 0.1×	144 1.1×	43	735
Lucas Marzec United States	14	1.1k 2.9×	160 0.5×	309 1.6×	9 0.0×	201 1.5×	31	1.3k
Jennifer L. Ellis United States	12	65 0.2×	76 0.3×	20 0.1×	55 0.3×	65 0.5×	39	444

Countries citing papers authored by Amol D. Dhamane

Since Specialization

Citations

This map shows the geographic impact of Amol D. Dhamane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amol D. Dhamane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amol D. Dhamane more than expected).

Fields of papers citing papers by Amol D. Dhamane

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amol D. Dhamane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amol D. Dhamane. The network helps show where Amol D. Dhamane may publish in the future.

Co-authorship network of co-authors of Amol D. Dhamane

This figure shows the co-authorship network connecting the top 25 collaborators of Amol D. Dhamane. A scholar is included among the top collaborators of Amol D. Dhamane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amol D. Dhamane. Amol D. Dhamane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cohen, Alexander T., Amol D. Dhamane, Xuejun Liu, et al.. (2024). Effectiveness and Safety of Extended Treatment Apixaban Versus Low-Molecular-Weight Heparin in Cancer-Associated Venous Thromboembolism. Journal of the National Comprehensive Cancer Network. 22(6). 397–403. 1 indexed citations

Liu, Xuejun, Daniela R. Junqueira, Kyle Fahrbach, et al.. (2024). Risk of Venous Thromboembolism by Cancer Type: A Network Meta-Analysis. Seminars in Thrombosis and Hemostasis. 50(3). 328–341. 8 indexed citations

Cohen, Alexander T., Amol D. Dhamane, Theodore Lee, et al.. (2023). Effectiveness and Safety of Apixaban vs Warfarin in Patients with Venous Thromboembolism with Risk Factors for Bleeding or for Recurrences. Advances in Therapy. 40(4). 1705–1735. 2 indexed citations

Dhamane, Amol D., Mauricio Ferri, Allison Keshishian, et al.. (2022). Effectiveness and Safety of Direct Oral Anticoagulants Among Patients with Non-valvular Atrial Fibrillation and Multimorbidity. Advances in Therapy. 40(3). 887–902. 7 indexed citations

Andrade, Jason G., Richard Godin, Tereza Lanitis, et al.. (2022). Cost-effectiveness of atrial fibrillation screening in Canadian community practice. Heart Rhythm O2. 4(2). 103–110. 2 indexed citations

Cohen, Alexander T., Amol D. Dhamane, Theodore Lee, et al.. (2022). Effectiveness and safety of apixaban vs warfarin among venous thromboembolism patients at high-risk of bleeding. PLoS ONE. 17(9). e0274969–e0274969. 2 indexed citations

Deitelzweig, Steven, Amiee Kang, Cristina Russ, et al.. (2021). EFFECTIVENESS AND SAFETY OF APIXABAN VERSUS WARFARIN IN OBESE PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION ENROLLED IN MEDICARE AND VETERAN AFFAIRS. Journal of the American College of Cardiology. 77(18). 1593–1593. 1 indexed citations

Deitelzweig, Steve, Amiee Kang, Cristina Russ, et al.. (2021). Effectiveness and Safety of Apixaban Versus Warfarin in Obese Patients with Nonvalvular Atrial Fibrillation Enrolled in Medicare and Veteran Affairs. The American Journal of Cardiology. 163. 43–49. 7 indexed citations

Deitelzweig, Steven, Allison Keshishian, Yan Zhang, et al.. (2021). Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients With Active Cancer. JACC CardioOncology. 3(3). 411–424. 32 indexed citations

10.

Lip, Gregory Y.H., Allison Keshishian, Amiee Kang, et al.. (2020). Effectiveness and Safety of Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Diabetes Mellitus. Mayo Clinic Proceedings. 95(5). 929–943. 20 indexed citations

11.

Deitelzweig, Steven, Allison Keshishian, Amiee Kang, et al.. (2019). EFFECTIVENESS AND SAFETY OF APIXABAN, DABIGATRAN AND RIVAROXABAN VERSUS WARFARIN IN OBESE PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION: ARISTOPHANES SUBGROUP ANALYSIS. Journal of the American College of Cardiology. 73(9). 435–435. 1 indexed citations

12.

Amin, Alpesh, Alessandra Bassalobre García, Xiaoyan Li, et al.. (2019). Effectiveness and safety of oral anticoagulants in older adults with non-valvular atrial fibrillation and heart failure. PLoS ONE. 14(3). e0213614–e0213614. 22 indexed citations

13.

Baker, Christine L., Amol D. Dhamane, Jack Mardekian, et al.. (2018). Comparison of Drug Switching and Discontinuation Rates in Patients with Nonvalvular Atrial Fibrillation Treated with Direct Oral Anticoagulants in the United States. Advances in Therapy. 36(1). 162–174. 20 indexed citations

14.

Dhamane, Amol D., Phil Schwab, Sari Hopson, et al.. (2016). Association between adherence to medications for COPD and medications for other chronic conditions in COPD patients. International Journal of COPD. Volume 12. 115–122. 30 indexed citations

15.

Dhamane, Amol D., Chad Moretz, Yunping Zhou, et al.. (2015). COPD exacerbation frequency and its association with health care resource utilization and costs. International Journal of COPD. 10. 2609–2609. 70 indexed citations

16.

Moretz, Chad, Yunping Zhou, Amol D. Dhamane, et al.. (2015). Development and Validation of a Predictive Model to Identify Individuals Likely to Have Undiagnosed Chronic Obstructive Pulmonary Disease Using an Administrative Claims Database. Journal of Managed Care & Specialty Pharmacy. 21(12). 1149–1159. 8 indexed citations

17.

Candrilli, Sean D., Amol D. Dhamane, Juliana Meyers, & Shuchita Kaila. (2015). Factors associated with inpatient readmission among managed care enrollees with COPD. Hospital Practice. 43(4). 199–207. 14 indexed citations

18.

D’Souza, Anna O., et al.. (2013). Clinical and Economic Burden of COPD in a Medicaid Population. COPD Journal of Chronic Obstructive Pulmonary Disease. 11(2). 212–220. 17 indexed citations

19.

Dhamane, Amol D., Bradley C. Martin, Diana Brixner, Teresa J. Hudson, & Qayyim Said. (2013). Metabolic Monitoring of Patients Prescribed Second-Generation Antipsychotics. Journal of Psychiatric Practice. 19(5). 360–374. 12 indexed citations

20.

Stanford, Richard H., Manan Shah, Anna O. D’Souza, Amol D. Dhamane, & Michael Schätz. (2012). Short-acting β-agonist use and its ability to predict future asthma-related outcomes. Annals of Allergy Asthma & Immunology. 109(6). 403–407. 137 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact